A collaboration between clinicians, the NHS and epilepsy charity SUDEP Action today comes to fruition with the launch of a new smartphone app. The app is designed to help you monitor your own epilepsy
The smartphone app is called the Epilepsy Self Monitor – or EpSMon. It has been developed by an impressive collaboration of various individuals and organisations. These include:
- People with epilepsy
- Health technology information experts
- Plymouth University
- Cornwall Partnership NHS Trust
- Royal Cornwall Hospital NHS Trust and
- SUDEP Action
The app is designed as an automatic way of monitoring health and wellbeing in people with epilepsy between their appointments with medical professionals. It assesses your personal information against known risk factors that might affect you in one of five categories. These include your seizures and your mental health, for instance.
Every three months, the app will ask the user questions that have traditionally formed part of GP consultations. These include questions about seizures and overall wellbeing, and when a person last had a medical appointment about their epilepsy.
When the user enters these pieces of information, the app assesses health and wellbeing and offers advice accordingly. For instance, the app may say: “Book an epilepsy review with your GP [family doctor]."
It is hoped that the app will encourage people with epilepsy to have more regular medical reviews. This can lead to getting better treatment outcomes, reduced accidents and an overall increase in health and wellbeing.
During consultations, the app can also help to inform your medical professional. This encourages a more productive appointment and, ultimately, leads to better medical care and reduction of risk.
EpSMon is now available for iPhone and Android. To download the app, visit the iTunes store or Google Play. Alternatively, look at a preview for more information. The price of the download may vary depending which country you live in.
You may also like...
Epilepsy Action this week releases the results of a new survey. Sadly, the results are not surprising. People with epilepsy all over the UK could – and should – have access to better treatments to improve their health and wellbeing